Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer-Reply. Shitara K, Tabernero J. JAMA Oncol 2021;7:633.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Shitara K, Tabernero J. Quantifying the Long-term Survival Benefit of Pembrolizumab for Patients With Advanced Gastric Cancer-Reply. JAMA Oncol 2021;7:633.
PMID: 33538773